Remdesivir in Solid Organ Recipients for COVID-19 Pneumonia

Transplantation Proceedings(2022)

引用 4|浏览6
暂无评分
摘要
•Remdesivir is effective in solid organ transplanted patients with COVID-19 needing hospitalization and supplementary oxygen.•Remdesivir is safe in solid organ transplant recipients•Lung-transplant recipients are at a high risk for COVID-19 mortality.
更多
查看译文
关键词
solid organ recipients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要